1.5.3 Drugs affecting the immune response
Adalimumab
Amgevita HCF 20mg/0.2ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Amgevita HCF 40mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Amgevita HCF 40mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Amgevita HCF 80mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Amgevita HCF 80mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Imraldi 40mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Imraldi 40mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Azathioprine
Azathioprine 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Azathioprine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Etrasimod
Velsipity 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Filgotinib
Jyseleca 100mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Jyseleca 200mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Golimumab
Simponi 100mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Simponi 50mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Simponi 50mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Guselkumab
Tremfya 200mg/20ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Tremfya OnePress 100mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Tremfya PushPen 200mg/2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Infliximab
Remsima 100mg powder for concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Remsima 120mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Mercaptopurine
Mercaptopurine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Mirikizumab
Omvoh 100mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Omvoh 300mg/15ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Ozanimod
Zeposia 0.23mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Zeposia 0.46mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Zeposia 0.92mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Risankizumab
Skyrizi 180mg/1.2ml solution for injection cartridges
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Skyrizi 360mg/2.4ml solution for injection cartridges
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Skyrizi 600mg/10ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Upadacitinib
Rinvoq 15mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Rinvoq 30mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Rinvoq 45mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Ustekinumab
Pyzchiva 130mg/26ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Pyzchiva 45mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Pyzchiva 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Wezenla 130mg/26ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Wezenla 45mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Wezenla 45mg/0.5ml solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Wezenla 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Vedolizumab
Entyvio 108mg/0.68ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Entyvio 108mg/0.68ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Entyvio 300mg powder for concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |